• 尊龙凯时



  • Welcome to Hubei Haosun Pharmaceutical Co.,Ltd.
    Home| Order | Contact us
    News

    Pass EDQM Audit

    Audit time: on August 21 to 23, 2024

    After three days of EDQM and AFMPS audit, our five API products Docetaxel anhydrous, Amisulpride, Granisetron Hydrochloride, Flumazenil and Irinotecan Hydrochloride approved by EDQM, and got an EUGMP certificate for API Granisetron Hydrochloride